The way I understand is that that design and manufacturing is the smaller share of the lead time for mRNA and non-mRNA. The pre-clinic and clinic trials along with any regulatory delay take most of the time. Still mRNA vaccines are better and cheaper than conventional vaccines after CAPEX is done. Both Moderna and Pfizer have trials running for Omicron.